Abstract: Disclosed herein are methods and compositions for treatment of a microbiome associated disorder. Further, disclosed herein are methods and compositions for modulating short chain fatty acid production in a subject.
Type:
Grant
Filed:
January 23, 2023
Date of Patent:
February 25, 2025
Assignee:
Pendulum Therapeutics Inc
Inventors:
Colleen Cutcliffe, John S. Eid, Tomer Altman, Orville G. Kolterman, James H. Bullard
Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
Type:
Grant
Filed:
July 22, 2020
Date of Patent:
March 19, 2024
Assignee:
Pendulum Therapeutics, Inc.
Inventors:
Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
Abstract: Disclosed herein are methods and compositions for treatment of a microbiome associated disorder. Further, disclosed herein are methods and compositions for modulating short chain fatty acid production in a subject.
Type:
Grant
Filed:
February 28, 2020
Date of Patent:
February 21, 2023
Assignee:
PENDULUM THERAPEUTICS, INC.
Inventors:
Colleen Cutcliffe, John S. Eid, Tomer Altman, Orville G. Kolterman, James H. Bullard
Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
Type:
Grant
Filed:
August 25, 2021
Date of Patent:
June 21, 2022
Assignee:
Pendulum Therapeutics, Inc.
Inventors:
Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
Type:
Grant
Filed:
March 26, 2020
Date of Patent:
March 22, 2022
Assignee:
Pendulum Therapeutics, Inc.
Inventors:
Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
Type:
Grant
Filed:
March 26, 2020
Date of Patent:
January 4, 2022
Assignee:
Pendulum Therapeutics, Inc.
Inventors:
Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
Type:
Grant
Filed:
October 12, 2018
Date of Patent:
November 24, 2020
Assignee:
Pendulum Therapeutics, Inc.
Inventors:
Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
Type:
Grant
Filed:
October 12, 2018
Date of Patent:
November 24, 2020
Assignee:
Pendulum Therapeutics, Inc.
Inventors:
Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
Type:
Grant
Filed:
October 12, 2018
Date of Patent:
June 9, 2020
Assignee:
Pendulum Therapeutics, Inc.
Inventors:
Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
Type:
Grant
Filed:
September 21, 2016
Date of Patent:
June 2, 2020
Assignee:
Pendulum Therapeutics, Inc.
Inventors:
Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
Abstract: The present disclosure provides methods for profiling a microbiome and therapeutic compositions for treatment. Additionally, the methods, systems, compositions and kits provided herein are directed to assessing or predicting health status in a subject. Some of the embodiments include generating a report.
Type:
Grant
Filed:
July 21, 2014
Date of Patent:
April 28, 2020
Assignee:
Pendulum Therapeutics, Inc.
Inventors:
Colleen Cutcliffe, John S. Eid, James H. Bullard